Newlink Genetics Corporation

Ames, IA 50010

Market Performance

NASDAQ: NLNK
Market Cap $275 Million
52 Week High $5.90
52 Week Low $25.17

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.14MM
First Award Date 09/01/06
Most Recent Award Date 09/01/09

Key Personnel

Last Name Name Awards Contact
Link Charles J. Link 3
Young Won-Bin Young 1
Aliberti Julio Aliberti 1
Aliberti Julio Aliberti 0
Karp Christopher L Karp 1

5 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-280
Budget: 09/01/09 - 08/31/11

DESCRIPTION (provided by applicant): Humans develop natural antibodies against a sugar molecule called Gal, which is present on proteins and lipids in most other species. These antibodies represent one of the strongest natural barriers to infection with bacteria, parasites and viruses. NewLink Genetics has licensed this technology as the HyperAc...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-08-051
Budget: 07/20/09 - 06/30/12

DESCRIPTION (provided by applicant): Indolamine 2,3-deoxygenase enzymes (IDO-1 and IDO-2) play important counter-regulatory roles in the immune system. IDO-mediated tryptophan catabolism induces T cell suppression, which plays a physiological role in suppressing autoimmune and allergic diseases, as well as in facilitating maternal/fetal toleranc...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 09/17/08 - 08/31/09

DESCRIPTION (provided by applicant): Humans develop natural antibodies against a sugar molecule called Gal, which is present on proteins and lipids in most other species. These antibodies represent one of the strongest natural barriers to infection with bacteria, parasites and viruses. NewLink Genetics has licensed this technology as the HyperAc...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 09/26/06 - 03/31/07

DESCRIPTION (provided by applicant): Project Summary/Abstract: The Human Genome Project has brought the field of functional genomics to the forefront of biological and pharmaceutical research. However, deciphering the function(s) of each gene in a high throughput format is complicated by alternative splicing and post-translational modifications ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/06 - 02/28/07

DESCRIPTION (provided by applicant): The availability of a reference human genome sequence provides the foundation for studying the genetic and molecular basis of human health and disease. Using a variety of modern technologies to study differential gene expression, large numbers of researchers in both academic and industrial settings look for c...